文献速递甲状腺疾病

促甲状腺激素与全因死亡率的关联:两样本孟德尔随机化研究

Association of Thyroid-Stimulating Hormone With All-Cause Mortality: A 2-Sample Mendelian Randomization Study.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

该研究采用两样本孟德尔随机化分析,以70个与促甲状腺激素(TSH)水平相关的单核苷酸多态性为工具变量,利用英国生物银行384344名参与者的死亡率数据,发现TSH每升高1个标准差与全因死亡风险降低相关(OR 0.972,95%CI 0.948-0.996),且该关联可能主要归因于呼吸系统疾病死亡。

要点

  • TSH每升高1个标准差,全因死亡风险降低(OR 0.972,95%CI 0.948-0.996)。
  • 该关联可能主要归因于呼吸系统疾病死亡(OR 0.881,95%CI 0.805-0.963)。
  • TSH遗传风险评分最高三分位组较参照组全因死亡风险降低(HR 0.947,95%CI 0.911-0.985)。

核心结论

  • 较高的TSH水平与较低的全因死亡风险存在因果关联,该关联可能主要归因于呼吸系统疾病死亡。

研究设计与样本

  • 两样本孟德尔随机化研究,以70个与TSH水平相关的单核苷酸多态性(P < 5 × 10-8)为工具变量。
  • 死亡率数据来自英国生物银行,纳入2006年至2010年间在英国22个评估中心招募的384344名参与者。
  • 采用Cox比例风险回归评估TSH遗传风险评分与全因死亡及特定原因死亡的关联。

主要发现

  • 英国生物银行中位随访9.00年期间,共有15557人死亡。
  • TSH每升高1个标准差与全因死亡风险降低相关(OR 0.972,95%CI 0.948-0.996)。
  • TSH每升高1个标准差与呼吸系统疾病死亡风险降低相关(OR 0.881,95%CI 0.805-0.963)。
  • 3个TSH遗传风险评分类别的全因死亡多变量风险比(95%CI)分别为1.00(参照)、0.976(0.940-1.014)和0.947(0.911-0.985),趋势P < .01。
  • 除消化系统疾病死亡外,遗传预测的TSH水平与心血管疾病、癌症、非癌症疾病及痴呆死亡均呈负相关,但无统计学显著性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Thyroid-stimulating hormone (TSH), as the most sensitive and specific marker of thyroid status, is associated with multiple health outcomes, including mortality. However, whether TSH levels are causally associated with the risk of mortality remains unclear. OBJECTIVE: This study aims to investigate the causal association between TSH levels and all-cause mortality using Mendelian randomization (MR) analyses. METHODS: MR analyses using single-nucleotide polymorphisms (SNPs) associated with TSH levels (P < 5 × 10-8) as instruments. Mortality data were obtained from the UK Biobank, including 384 344 participants who were recruited from 22 assessment centers across the UK taken between 2006 and 2010. Cox proportional hazards regression was used to estimate the association of the TSH genetic risk score (GRS) with all-cause and cause-specific mortality. RESULTS: 15 557 individuals died during a median of 9.00 years of follow-up in the UK Biobank. A total of 70 SNPs were included in the MR analysis. The main MR analyses showed that 1 SD increase in TSH was associated with a decreased risk of all-cause mortality (OR 0.972, 95% CI 0.948-0.996), which may be largely attributed to respiratory disease mortality (OR 0.881, 95% CI 0.805-0.963). The multivariable hazard ratios (HRs) (95% CI) of all-cause mortality across 3 TSH GRS categories were 1.00 (reference), 0.976 (0.940-1.014), and 0.947 (0.911-0.985), respectively (P for trend < .01). Moreover, except digestive diseases mortality, genetically predicted TSH levels were negatively associated with mortality from CVD, cancer, noncancer diseases causes, and dementia, although not statistically significant. CONCLUSION: Higher TSH levels were causally associated with lower risk of all-cause mortality, which may be largely attributed to respiratory disease mortality.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Gu Y, Song Z, Li Q, et al. Association of Thyroid-Stimulating Hormone With All-Cause Mortality: A 2-Sample Mendelian Randomization Study. J Clin Endocrinol Metab. 2023. PMID: 36658102. doi:10.1210/clinem/dgad025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。